Fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in non-insulin-dependent diabetics and in control subjects
- PMID: 3604753
- DOI: 10.1111/j.0954-6820.1987.tb03359.x
Fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in non-insulin-dependent diabetics and in control subjects
Abstract
We have studied fasting, postprandial and postprandial plus glucagon-stimulated plasma C-peptide levels in 149 non-insulin-dependent diabetics treated either with diet or oral drugs and in 101 non-diabetic control subjects. Diet-treated diabetics showed the highest fasting, postprandial and post-glucagon C-peptide levels in both sexes. In men, diabetics treated with oral drugs showed lower postprandial and glucagon-stimulated C-peptide levels than control subjects, while in women C-peptide levels in this group of diabetics were similar to those in control subjects. The distribution of individual plasma C-peptide levels was wide in non-insulin-dependent diabetics and control subjects and there was considerable overlapping in plasma C-peptide distribution for diabetics and control subjects. Fasting and post-glucagon plasma C-peptide levels in diabetics showed an inverse association to plasma glucose levels and a positive association to degree of obesity, but no association with the known duration of diabetes.
Similar articles
-
Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity.Diabetes Care. 1988 Apr;11(4):318-22. doi: 10.2337/diacare.11.4.318. Diabetes Care. 1988. PMID: 3042307
-
Glucagon-C-peptide test as a measure of insulin requirement in type 2 diabetes: evaluation of stopping insulin therapy in eleven patients.Ann Clin Res. 1987;19(3):178-82. Ann Clin Res. 1987. PMID: 3314647
-
Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes.Diabetologia. 1989 May;32(5):305-11. doi: 10.1007/BF00265547. Diabetologia. 1989. PMID: 2666217
-
Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.Gerontology. 1986;32(6):317-26. doi: 10.1159/000212810. Gerontology. 1986. PMID: 3556328
-
Prevalence of fasting hyperglycemia and known non-insulin-dependent diabetes mellitus classified by plasma C-peptide: Fredericia survey of subjects 60-74 yr old.Diabetes Care. 1987 Jan-Feb;10(1):26-32. doi: 10.2337/diacare.10.1.26. Diabetes Care. 1987. PMID: 3552511
Cited by
-
Arginine is preferred to glucagon for stimulation testing of β-cell function.Am J Physiol Endocrinol Metab. 2014 Oct 15;307(8):E720-7. doi: 10.1152/ajpendo.00149.2014. Epub 2014 Aug 26. Am J Physiol Endocrinol Metab. 2014. PMID: 25159323 Free PMC article.
-
Serum C-peptide assay of patients with hyperglycemic emergencies at the Lagos State University Teaching Hospital (LASUTH), Ikeja.Int Arch Med. 2014 Nov 28;7:50. doi: 10.1186/1755-7682-7-50. eCollection 2014. Int Arch Med. 2014. PMID: 25945127 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical